COVID19 Flashcards
What labs may be indicative of COVID? (2)
Leukopenia
Lymphopenia
Name 4 physiological effects of angiotensin 2
- vasoconstriction - hypertension
- inflammation - ards
- fibrosis - cardiac fibrosis
- thrombosis
- proliferation
What imaging features may be indicative of COVID? (3)
- Bilateral
- ground glass opacities
- Peripheral distribution
Name and describe the 3 phases of COVID
- Stage 1: early infection- mild constitutional symptoms, fever, dry cough, diarrhoea, headache
- stage 2: pulmonary phase- sob, hypoxia
- stage 3: hyperinflammation- ARDS, sirs/shock, cardiac failure
Name 3 clinical signs of stage 1 covid infection
- Lymphopenia
- increased prothrombin time PT
- increased D dimer and LDH (lactate dehydrogenase) (mild)
Name 3 clinical signs of stage 2 covid infection
- abnormal chest imaging: bilateral ground glass opacities etc
- transaminitis ( hyper transaminases- synthesise amino acids)
- low to normal procalcitonin (calcium homeostasis)
Name 3 clinical signs of stage 3 covid infection
- Elevated inflammatory markers: CRP, LDL, il-6, D dimer, ferritin
- elevated troponin (cardiac damage)
- nt-proBNP elevated (heart failure)
Name 3 important SARS cov 2 variants
• B.1.1.7 variant or variant of concern voc 202012 / 01 or 20i/501y.V1 found in uk late 2020. More transmissible and cause more severe disease
• b.1.351 variant or 20H/501Y.V2 found late 2020 sa. More transmissable and evade immune responses but does not impact severity
. P.1 variant or 20J/501Y.V3. Found in Japan in travellers from Brazil late 2020. Several mutations with potential to increase transmissibility and impact immunity.
What are the major thrombotic complications in COVID?
Hypercoagulation
• vTE including DVT and pe
• arterial thrombosis: stroke, mi, limb ischaemia
Higher risk in ICU
What are the major coagulation abnormalities in Covid? (4)
- High fibrinogen
- high D dimer
- mild prolongation pt
- Prolongation aptt
Which drug may have mortality benefit COVID?
Dexamethasone
Which drug may be useful for hospitilised COVID patients with hypoxia not yet on oxygen?
Remdesivir (nucleoside analogue)
Avoid dexamethasone
Which 3 drugs may be useful for hospitilised COVID patients with hypoxia receiving low flow oxygen?
- remdesivir
- dexamethasone
- if inflammatory markers still high, add tocilizumab (immunosuppressant)
Which 3 drugs may be useful for hospitilised COVID patients with hypoxia receiving high flow oxygen Or non invasive ventilation?
• Low dose dexamethasone
• add tocilizumab if being transferred to or are in ICU
. Add remdesivir but reserve for low-flow patients if short supply
Which 2 drugs may be useful for hospitilised COVID patients with severe disease requiring mechanical ventilation or extracorporeal membrane oxygenation?
- Low dose dexamethasone
- ICU: add tocilizumab
- avoid remdesivir